Joseph Tarantino, DPM
Foot Surgery · Howard Beach, NYNPI 1891737011
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Organogenesis Inc. at 27.6% of the total. Among foot surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $31.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$2K
- Smith+Nephew$747
- Abbott$707
- Stryker$607
- AbbVie$492
- Kerecis Limited$446
- plus $3K from 29 others
What the payments were for
- Speaking & faculty fees$1071%
- Travel & lodging$10%
- Food & beverage$7,57699%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 79 | $2,122 |
| Smith+Nephew | 24 | $747 |
| Abbott | 7 | $707 |
| Stryker(2 entities) | 12 | $607 |
| AbbVie(2 entities) | 21 | $492 |
| Kerecis Limited | 4 | $446 |
| Lifenet Health | 6 | $304 |
| Hydrofera LLC | 6 | $260 |
| Integra Lifesciences Corporation | 14 | $254 |
| KCI USA, Inc. | 3 | $191 |
| Merck | 11 | $168 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $149 |
| Advanced Oxygen Therapy Inc. | 2 | $147 |
| Novo Nordisk | 10 | $145 |
| Medtronic | 1 | $108 |
| Kowa Pharmaceuticals America, Inc. | 7 | $104 |
| Paratek Pharmaceuticals, Inc. | 4 | $90 |
| Convatec Inc. | 4 | $68 |
| Aroa Biosurgery Incorporated | 4 | $66 |
| Sanofi Pasteur Inc. | 3 | $57 |
| Bioventus LLC | 2 | $49 |
| Amgen | 2 | $48 |
| Mannkind Corporation | 2 | $48 |
| Amarin Pharma, Inc. | 2 | $38 |
| Biocomposites Inc | 1 | $38 |
| AstraZeneca | 1 | $33 |
| Solventum Corporation | 1 | $29 |
| Exact Sciences | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Derma Sciences, Inc. | 1 | $22 |
| Next Science LLC | 1 | $22 |
| Pfizer | 1 | $22 |
| Medela LLC | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$1,026
- Supera peripheral stent system$396
- Kerecis Omega3 SurgiClose$294
- ORTHOLOC 2 LAPIFUSE$279
- TheraGenesis Wound Matrix$237
- CITREFIX$167
- PROPHECY$167
- CUTIMED SORBION$162
- PuraPly$155
- PROSTEP MICA$152
- Kerecis Omega3 GraftGuide$150
- JUBLIA$149
- VAC ULTA$146
- VAC VERAFLO CLEANSE CHOICE$146
- PREVENA$146
- ACTIVAC$146
- SNAP$146
- SUPERA$138
- GRAFIX PL$129
- CHARLOTTE$127
How this compares
$7,684 in reported general payments places this provider in the 90th percentile of 294 foot surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 39 | $8,513 |
| SantylCollagenase Clostridium Hist. | 16 | $5,548 |
| Clotrimazole | 61 | $3,214 |
| Hydrocortisone | 19 | $1,068 |
| Ammonium Lactate | 35 | $776 |
| Meloxicam | 30 | $724 |
| Ciclopirox | 12 | $371 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $343 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $257 |
| Cefadroxil | 32 | $219 |
| Doxycycline Hyclate | 26 | $166 |
| Mupirocin | 17 | $119 |
| Triamcinolone Acetonide | 16 | $72 |
| Levofloxacin | 11 | $43 |
| Prednisone | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $747 | $5,54816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 294 foot surgery providers in New York.
Other foot surgery in Howard Beach
- Ronald GubermanRidgewood$337K
- John JackaloneBethpage$66K
- David WongBronx$45K
- Berdj StepanianWhite Plains$26K
- Lawrence SantiBrooklyn$25K
- David GitlinBayside$24K
- Rick DelmonteNew York$21K
- Corrine RenneFranklin Square$20K
- Charles MorelliMamaroneck$18K
- Evan BrethBrooklyn$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.